SalioGen Therapeutics
Provider of gene editing platform for cell and gene therapies for inherited diseases. The company offers the proprietary Exact DNA Integration Technology (EDIT) platform, which is a genome engineering technology that is mammal-derived, for use non-viral gene therapy for patients suffering from inherited diseases and genetic diseases like Familial hypercholesterolemia, and Inherited macular degeneration. The company…
Funding snapshot
About
Provider of gene editing platform for cell and gene therapies for inherited diseases. The company offers the proprietary Exact DNA Integration Technology (EDIT) platform, which is a genome engineering technology that is mammal-derived, for use non-viral gene therapy for patients suffering from inherited diseases and genetic diseases like Familial hypercholesterolemia, and Inherited macular degeneration. The company was founded in 2019 and headquartered in United States. It has raised $152.2M in series b funding, with backing from PBM Capital, GordonMD Global Investments, EPIQ, Fidelity Investments, and others. The company operates in the Life Sciences - Rare Diseases, Life Sciences - Gene Therapy, Life Sciences - Genomics space. Its offerings span Rare Diseases - Drugs - Diversified.
Business model
Rare Diseases > Drugs > Diversified,
Genomics > Enabling Technologies > Technology Platforms > Gene Editing
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.
Raising like SalioGen Therapeutics?
Analyze your pitch deck before your next raise.
Analyze My Deck →